BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 22023620)

  • 1. Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)?
    Toubai T; Tanaka J; Paczesny S; Shono Y; Reddy P; Imamura M
    Curr Stem Cell Res Ther; 2012 May; 7(3):229-39. PubMed ID: 22023620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-transplantation vitamin E levels and acute graft-versus-host disease after non-myeloablative allogeneic hematopoietic cell transplantation.
    Gjærde LK; Ostrowski SR; Jørgensen NR; Schierbeck F; Andersen NS; Friis LS; Kornblit B; Petersen SL; Schjødt I; Sengeløv H
    Transpl Immunol; 2022 Oct; 74():101650. PubMed ID: 35718288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
    Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does transfusion-associated graft-versus-host disease compare to hematopoietic cell transplantation-associated graft-versus-host disease?
    Aizawa K; Peltier D; Matsuki E; Toubai T
    Transfus Apher Sci; 2022 Apr; 61(2):103405. PubMed ID: 35210194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34
    Barba P; Martino R; Zhou Q; Cho C; Castro-Malaspina H; Devlin S; Esquirol A; Giralt S; Jakubowski AA; Caballero D; Maloy M; Papadopoulos EB; Piñana JL; Fox ML; Márquez-Malaver FJ; Valcárcel D; Solano C; López-Corral L; Sierra J; Perales MA
    Biol Blood Marrow Transplant; 2018 May; 24(5):964-972. PubMed ID: 29305194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of acute graft-versus-host disease in adult T-cell leukemia-lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation.
    Inoue Y; Nishimura N; Murai M; Matsumoto M; Watanabe M; Yamada A; Izaki M; Nosaka K; Matsuoka M
    Int J Hematol; 2022 Mar; 115(3):435-439. PubMed ID: 34705226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E and acute graft-versus-host disease after myeloablative allogeneic hematopoietic cell transplantation.
    Gjaerde LK; Ostrowski SR; Minculescu L; Andersen NS; Friis LS; Kornblit B; Petersen SL; Schjødt I; Sengeløv H
    Eur J Haematol; 2021 Mar; 106(3):417-424. PubMed ID: 33314420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma biomarkers in graft-versus-host disease: a new era?
    Paczesny S; Levine JE; Braun TM; Ferrara JL
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):33-8. PubMed ID: 19147075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease.
    Mohamed FA; Thangavelu G; Rhee SY; Sage PT; O'Connor RS; Rathmell JC; Blazar BR
    Front Immunol; 2021; 12():757836. PubMed ID: 34712243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?
    Zeiser R; Blazar BR
    Blood; 2016 Jun; 127(25):3117-26. PubMed ID: 26994149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study.
    Ishida T; Hishizawa M; Kato K; Tanosaki R; Fukuda T; Takatsuka Y; Eto T; Miyazaki Y; Hidaka M; Uike N; Miyamoto T; Tsudo M; Sakamaki H; Morishima Y; Suzuki R; Utsunomiya A
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1731-9. PubMed ID: 24090597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation.
    Iliopoulou BP; Hsu K; Pérez-Cruz M; Tang SW; Pang WW; Erkers T; Kambham N; Freeman GJ; Dekruyff RH; Meyer EH
    Blood Adv; 2019 Nov; 3(21):3419-3431. PubMed ID: 31714958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor.
    Jiang H; Fu D; Bidgoli A; Paczesny S
    Front Immunol; 2021; 12():761448. PubMed ID: 34675938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances of Acute Kidney Injury in Hematopoietic Cell Transplantation.
    Miyata M; Ichikawa K; Matsuki E; Watanabe M; Peltier D; Toubai T
    Front Immunol; 2021; 12():779881. PubMed ID: 35058924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: considerations for evidence-based GVHD prophylaxis.
    Nakamura R; Forman SJ
    Expert Rev Hematol; 2014 Jun; 7(3):407-21. PubMed ID: 24702163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.
    Staffas A; Burgos da Silva M; van den Brink MR
    Blood; 2017 Feb; 129(8):927-933. PubMed ID: 27940475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells and acute graft-versus-host disease after allogeneic stem cell transplantation.
    Mohty M
    Leuk Lymphoma; 2007 Sep; 48(9):1696-701. PubMed ID: 17786704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation.
    Cheng AP; Cheng MP; Loy CJ; Lenz JS; Chen K; Smalling S; Burnham P; Timblin KM; Orejas JL; Silverman E; Polak P; Marty FM; Ritz J; De Vlaminck I
    Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35058359
    [No Abstract]   [Full Text] [Related]  

  • 20. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.